Vaccines containing ribavirin and methods of use thereof
Number of patents in Portfolio can not be more than 2000
United States of America Patent
Stats
-
Feb 22, 2005
Issued Date -
N/A
app pub date -
Aug 15, 2001
filing date -
Aug 17, 2000
priority date (Note) -
Expired
status (Latency Note)
Importance
Abstract
Compositions and methods for enhancing the effect of vaccines in animals, such as domestic, sport, or pet species, and humans are disclosed. More particularly, vaccine compositions comprising ribavirin and an antigen, preferably an antigen that has an epitope present in Hepatitis C virus (HCV), are disclosed for use in treating and preventing disease, preferably HCV infection.
First Claim
Family
International Classification(s)
Cited Art Landscape
Patent Citation Ranking
Recipient Email Address
Recipient Email Address
Comment
Recipient Email Address
Add to Portfolio(s)
To add this patent to one, or more, of your portfolios, simply click the add button.
This Patent is in these Portfolios:
Add to additional portfolios:
Last Refreshed On:
Changes done successfully